Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia

Aníbal A. Teherán; Gabriel Camero; Carolina Hernández; Luis Perez-Garcia; Renato Gúzman; Alberto Paniz-Mondolfi; Juan David Ramírez

doi:10.1002/jmv.26059

Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia

Título traducido de la contribución: Posibles efectos negativos del uso gratuito de cloroquina para el manejo de COVID-19 en Colombia

Aníbal A. Teherán, Gabriel Camero, Carolina Hernández, Luis Perez-Garcia, Renato Gúzman, Alberto Paniz-Mondolfi, Juan David Ramírez

Producción científica: Contribución a una revista › Comentario/Debate › revisión exhaustiva

1 Cita (Scopus)

Resumen

La pandemia de la enfermedad por coronavirus 2019 (COVID-19) ha supuesto un reto para los sistemas sanitarios de todo el mundo. Lamentablemente, el fracaso se ha hecho evidente con el colapso de los países de altos ingresos, donde los sistemas de excelente calidad y eficientes -con recursos suficientes y tecnología científica avanzada para establecer estrategias de salud pública sólidas basadas en modelos matemáticos ajustados para atender a la COVID-191- han sufrido una tensión significativa.

En la actualidad, no existen intervenciones farmacológicas eficaces con suficiente evidencia científica para tratar la COVID-19. Impulsada por el impacto epidemiológico y clínico de su rápida propagación, y las alarmantes tasas de letalidad superiores al 10% en algunos países, la necesidad de un manejo intrahospitalario -especialmente en las unidades de cuidados intensivos (UCI)- dirigió la atención de la salud pública hacia experiencias farmacológicas previas evaluadas en otras cepas de coronavirus.

Título traducido de la contribución	Posibles efectos negativos del uso gratuito de cloroquina para el manejo de COVID-19 en Colombia
Idioma original	Inglés estadounidense
Páginas (desde-hasta)	2254-2256
Número de páginas	2
Publicación	Journal of Medical Virology
Volumen	92
N.º	11
DOI	https://doi.org/10.1002/jmv.26059
Estado	En prensa - may. 26 2020

Áreas temáticas de ASJC Scopus

Virología
Enfermedades infecciosas

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1002/jmv.26059

Otros archivos y enlaces

Citar esto

@article{eb4effb9c3a8412980f1590d4a28206d,

title = "Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia",

abstract = "Coronavirus disease 2019 (COVID‐19) pandemic has challenged healthcare systems around the world. Unfortunately, failure has become evident with the collapse of high‐income countries where excellent‐quality and efficient systems—with enough resources and advanced scientific technology to establish strong public health strategies based on mathematical models adjusted to serve COVID‐191—have undergone significant strain.Currently, there are no effective pharmacological interventions with sufficient scientific evidence to treat COVID‐19. Fueled by the epidemiological and clinical impact of its rapid spread, and the alarming fatality rates of over 10% in some countries, the need for in‐hospital management—especially in intensive care units (ICU)—geared public health attention towards previous pharmacological experiences evaluated in other coronavirus strains.",

author = "Teher{\'a}n, {An{\'i}bal A.} and Gabriel Camero and Carolina Hern{\'a}ndez and Luis Perez-Garcia and Renato G{\'u}zman and Alberto Paniz-Mondolfi and Ram{\'i}rez, {Juan David}",

year = "2020",

month = may,

day = "26",

doi = "10.1002/jmv.26059",

language = "English (US)",

volume = "92",

pages = " 2254--2256",

journal = "Journal of Medical Virology",

issn = "0146-6615",

publisher = "Wiley-Liss Inc.",

number = "11",

}

TY - JOUR

T1 - Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia

AU - Teherán, Aníbal A.

AU - Camero, Gabriel

AU - Hernández, Carolina

AU - Perez-Garcia, Luis

AU - Gúzman, Renato

AU - Paniz-Mondolfi, Alberto

AU - Ramírez, Juan David

PY - 2020/5/26

Y1 - 2020/5/26

N2 - Coronavirus disease 2019 (COVID‐19) pandemic has challenged healthcare systems around the world. Unfortunately, failure has become evident with the collapse of high‐income countries where excellent‐quality and efficient systems—with enough resources and advanced scientific technology to establish strong public health strategies based on mathematical models adjusted to serve COVID‐191—have undergone significant strain.Currently, there are no effective pharmacological interventions with sufficient scientific evidence to treat COVID‐19. Fueled by the epidemiological and clinical impact of its rapid spread, and the alarming fatality rates of over 10% in some countries, the need for in‐hospital management—especially in intensive care units (ICU)—geared public health attention towards previous pharmacological experiences evaluated in other coronavirus strains.

AB - Coronavirus disease 2019 (COVID‐19) pandemic has challenged healthcare systems around the world. Unfortunately, failure has become evident with the collapse of high‐income countries where excellent‐quality and efficient systems—with enough resources and advanced scientific technology to establish strong public health strategies based on mathematical models adjusted to serve COVID‐191—have undergone significant strain.Currently, there are no effective pharmacological interventions with sufficient scientific evidence to treat COVID‐19. Fueled by the epidemiological and clinical impact of its rapid spread, and the alarming fatality rates of over 10% in some countries, the need for in‐hospital management—especially in intensive care units (ICU)—geared public health attention towards previous pharmacological experiences evaluated in other coronavirus strains.

UR - http://www.scopus.com/inward/record.url?scp=85085935432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085935432&partnerID=8YFLogxK

U2 - 10.1002/jmv.26059

DO - 10.1002/jmv.26059

M3 - Comment/debate

C2 - 32458488

AN - SCOPUS:85085935432

SN - 0146-6615

VL - 92

SP - 2254

EP - 2256

JO - Journal of Medical Virology

JF - Journal of Medical Virology

IS - 11

ER -

Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia

Resumen

Áreas temáticas de ASJC Scopus

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto